1346601-18-0
1346601-18-0
Chemical Structure
5-Aminosalicylic Acid-d3 hydrochloride
Synonym(s): Mesalamine-D3 hydrochloride; 5-ASA-D3 hydrochloride; Mesalazine-D3 hydrochloride
- CAS No.: 1346601-18-0
- Formula:C7H5D3ClNO3
- Molecular Weight:192.61
IUPAC Name: 5-amino-2-hydroxybenzoic-3,4,6-d3 acid hydrochloride
InChIKey: KKRSNTURHSOKTM-KADUPEOVSA-N
SMILES: OC(C1=C(C([2H])=C([2H])C(N)=C1[2H])O)=O.Cl
Biological Activity: 5-Aminosalicylic Acid-d3 (hydrochloride) is the deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) hydrochloride acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
5-Aminosalicylic Acid-d3 hydrochloride | 99.00% | 5-Aminosalicylic Acid-d3 (hydrochloride) is the deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) hydrochloride acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-Aminosalicylic Acid (Standard) | 99.54% | 5-Aminosalicylic Acid (Standard) is the analytical standard of 5-Aminosalicylic Acid. This product is intended for research and analytical applications. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-Aminosalicylic acid-13C6 | 5-Aminosalicylic acid-13C6 is the 13C labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-Aminosalicylic acid-d3 | 99.38% | 5-Aminosalicylic acid-d3 is the deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-Aminosalicylic acid-d3 disodium | 5-Aminosalicylic acid-d3 disodium is deuterated labeled 5-Aminosalicylic Acid (HY-15027). 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB.5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-Aminosalicylic acid-d7 | 5-Aminosalicylic acid-d7 (5-ASA-d7; Mesalamie-d7; Mesalazie-d7) is deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
5-Aminosalicylic Acid | 99.97% | 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
